After the news release of Roche’s merger proposal for the remaining stake in Genentech today, I thought the time was right to complete my previous post.
To reiterate, there were two important pieces of information that I found useful after completing my study. First, the loss in market cap amongst the small cap companies comprising the [...]

Continue reading ...